Yea but if they fail they will have to sell even more shares at an even lower price than .005 which will drastically reduce their ability to raise any capital. Capital that keep in mind goes to executive compensation not R&D. If tests fail then the looming bankruptcy will only come sooner.
Market Data 
Markets 
AI
